Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Raleigh

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Biorxiv : the Preprint Server for Biology|August 2, 2024
Glioblastoma Neurovascular Progenitor Orchestrates Tumor Cell Type DiversityElisa Fazzari, Daria J Azizad, Kwanha Yu, et al.
Nature Communications|January 12, 2024
Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistanceHarish N Vasudevan, Emily Payne, Cyrille L Delley, et al.
Molecular Cell|October 20, 2018
Cilia-Associated Oxysterols Activate SmoothenedDavid R Raleigh, Navdar Sever, Pervinder K Choksi, et al.
The Journal of Clinical Investigation|February 16, 2026
STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma modelShashwat Tripathi, Hinda Najem, Lisa Hurley, et al.
Cell Genomics|May 24, 2024
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeH Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastomaJacob S Young, Nam Woo Cho, Calixto-Hope G Lucas, et al.
JAMA Network Open|August 17, 2023
Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to ImmunotherapyHarish N Vasudevan, Cyrille Delley, William C Chen, et al.
Cancer Discovery|July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable DependenciesBriana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
Cancer Discovery|May 14, 2024
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to RadiotherapyAbrar Choudhury, Martha A Cady, Calixto-Hope G Lucas, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|August 2, 2024
Glioblastoma Neurovascular Progenitor Orchestrates Tumor Cell Type DiversityElisa Fazzari, Daria J Azizad, Kwanha Yu, et al.
Nature Communications|January 12, 2024
Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistanceHarish N Vasudevan, Emily Payne, Cyrille L Delley, et al.
Molecular Cell|October 20, 2018
Cilia-Associated Oxysterols Activate SmoothenedDavid R Raleigh, Navdar Sever, Pervinder K Choksi, et al.
The Journal of Clinical Investigation|February 16, 2026
STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma modelShashwat Tripathi, Hinda Najem, Lisa Hurley, et al.
Cell Genomics|May 24, 2024
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeH Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastomaJacob S Young, Nam Woo Cho, Calixto-Hope G Lucas, et al.
JAMA Network Open|August 17, 2023
Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to ImmunotherapyHarish N Vasudevan, Cyrille Delley, William C Chen, et al.
Cancer Discovery|July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable DependenciesBriana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
Cancer Discovery|May 14, 2024
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to RadiotherapyAbrar Choudhury, Martha A Cady, Calixto-Hope G Lucas, et al.
Pageof 17